The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.60
Bid: 38.60
Ask: 38.70
Change: 0.40 (1.05%)
Spread: 0.10 (0.259%)
Open: 38.30
High: 40.70
Low: 37.70
Prev. Close: 38.20
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Revised Banking Arrangements & Operational Update

1 May 2018 07:00

RNS Number : 6644M
Accrol Group Holdings PLC
01 May 2018
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

1 May 2018

Accrol Group Holdings plc

("Accrol", the "Company" or the "Group")

AIM: ACRL

 

REVISED BANKING ARRANGEMENTS, OPERATIONAL UPDATE AND CURRENT TRADING

 

Revised Banking Arrangements

 

Further to the information provided in the Trading Update announced on 19 March 2018 and following constructive discussions with its lender, Accrol announces that a number of matters regarding the Group's borrowing facilities have been agreed as outlined below:

 

· EBITDA covenants tests in respect of the periods ended 30 April 2018 and ending 31 July 2018 have been waived;

· the scheduled reduction in the limit of the Revolving Credit Facility which was due to occur on 30 April 2018 has been deferred until 31 October 2018; and

· indicative terms have been established for the lease funding of the new conversion line being installed at the Leyland plant in the next three months, which will allow the business to service major new business wins.

 

These revised banking arrangements, which are subject to the Company complying with certain undertakings to the lender during May 2018 (with which the Board expects to be able to comply) will help to support the growth of the business and enable the new management team to pursue the business recovery plan.

 

Operational Update

The Group is pleased to announce that it has recently entered heads of terms on the exit from the onerous central distribution hub in Skelmersdale. This planned exit is expected to have a positive impact on annualised profits, as previously reported, of at least £5 million.

Current Trading

 

The Company continues to trade in line with current market expectations.

 

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Gareth Jenkins, Chief Executive Officer

Tel: +44 (0) 1254 278 844

Martin Leitch, Interim Chief Finance Officer

Tel: +44 (0) 1254 278 844

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Andrew Jones

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

 Tel: +44 (0) 203 829 5000

 

 

Belvedere Communications Limited

 

Cat Valentine (cvalentine@belvederepr.com)

Tel: +44 (0) 7715 769 078

 

Notes to Editors

 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to the UK's largest retailers. 

Accrol operates from three sites:

· A manufacturing, storage and distribution facility in Blackburn;

· A facial tissue plant, also in Blackburn; and

· A manufacturing, storage and distribution facility in Leyland.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGFDZGNGRZZ
Date   Source Headline
14th Jul 20217:00 amRNSAudited Final Results
7th Jul 20217:00 amRNSNotice of Results and Online Investor Presentation
4th Jun 202110:38 amRNSTR-1
18th May 20214:41 pmRNSSecond Price Monitoring Extn
18th May 20214:36 pmRNSPrice Monitoring Extension
18th May 20212:06 pmRNSSecond Price Monitoring Extn
18th May 20212:00 pmRNSPrice Monitoring Extension
18th May 202111:05 amRNSSecond Price Monitoring Extn
18th May 202111:00 amRNSPrice Monitoring Extension
18th May 20219:06 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
18th May 20217:00 amRNSTrading Update
9th Apr 20217:00 amRNSAcquisition of highly scalable wet wipes business
8th Apr 20216:04 pmRNSCorrection: TR-1
8th Apr 20215:58 pmRNSCorrection: TR-1
30th Mar 20217:00 amRNSTR-1
18th Mar 20213:23 pmRNSTR-1
5th Mar 20217:11 amRNSImplementation of LTIP and PDMR dealing
14th Jan 20217:00 amRNSPDMR Dealings
12th Jan 20217:00 amRNSHalf Year Results
7th Jan 20217:00 amRNSOnline HY 21 Investor Presentation
17th Dec 20207:00 amRNSNotice of Half Year Results
15th Dec 20207:00 amRNSOnline Investor Presentation
14th Dec 202011:05 amRNSSecond Price Monitoring Extn
14th Dec 202011:00 amRNSPrice Monitoring Extension
14th Dec 20209:05 amRNSSecond Price Monitoring Extn
14th Dec 20209:00 amRNSPrice Monitoring Extension
11th Dec 20208:51 amRNSTR-1
2nd Dec 20207:00 amRNSAppointment of Chief Financial Officer
27th Nov 202012:48 pmRNSTR-1
26th Nov 20207:00 amRNSTR-1
25th Nov 20207:00 amRNSCompletion of Acquisition
24th Nov 20201:54 pmRNSTR-1
24th Nov 20201:44 pmRNSTR-1
24th Nov 202011:28 amRNSTR-1
24th Nov 202010:54 amRNSTR-1
24th Nov 20207:00 amRNSPDMR Dealing
23rd Nov 20208:00 amRNSAdmission of Shares & Total Voting Rights
20th Nov 202011:32 amRNSResult of General Meeting
20th Nov 20207:00 amRNSResult of Open Offer
6th Nov 202011:55 amRNSTR-1
4th Nov 20205:13 pmRNSPosting of Circular
3rd Nov 20207:00 amRNSConfirmation of Successful Placing
2nd Nov 20204:59 pmRNSAcquisition and Launch of ABB
2nd Nov 20207:00 amRNSCOVID-19 Business Update
27th Oct 20202:44 pmRNSResult of AGM
25th Sep 20208:00 amRNSNotice of AGM and Posting of Accounts
2nd Sep 20207:00 amRNSAudited Final Results
25th Aug 20207:00 amRNSNotice of Results and Online Investor Presentation
22nd May 202012:40 pmRNSTR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.